|
EP3341007B1
(en)
|
2015-08-28 |
2020-12-23 |
Cornell University |
Malt1 inhibitors and uses thereof
|
|
HK1252752A1
(zh)
*
|
2015-11-13 |
2019-05-31 |
Novartis Ag |
新型吡唑并嘧啶衍生物
|
|
EP3455219A4
(en)
|
2016-05-10 |
2019-12-18 |
C4 Therapeutics, Inc. |
AMINE-RELATED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
|
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
WO2017197055A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
|
EP3454862B1
(en)
|
2016-05-10 |
2024-09-11 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
|
JP7142022B2
(ja)
*
|
2017-03-08 |
2022-09-26 |
コーネル・ユニバーシティー |
Ｍａｌｔ１の阻害剤およびそれらの使用
|
|
CN110769822A
(zh)
|
2017-06-20 |
2020-02-07 |
C4医药公司 |
用于蛋白降解的n/o-连接的降解决定子和降解决定子体
|
|
WO2019043217A1
(en)
|
2017-09-04 |
2019-03-07 |
F. Hoffmann-La Roche Ag |
DIHYDROBENZIMIDAZOLONES
|
|
WO2019043208A1
(en)
|
2017-09-04 |
2019-03-07 |
F. Hoffmann-La Roche Ag |
DIHYDROQUINOLINONES
|
|
WO2019043214A1
(en)
|
2017-09-04 |
2019-03-07 |
F. Hoffmann-La Roche Ag |
glutarimide
|
|
CN111372585A
(zh)
|
2017-11-16 |
2020-07-03 |
C4医药公司 |
用于靶蛋白降解的降解剂和降解决定子
|
|
US11571427B2
(en)
|
2017-12-28 |
2023-02-07 |
The General Hospital Corporation |
Targeting the CBM signalosome complex induces regulatory T cells to inflame the tumor microenvironment
|
|
KR20210018199A
(ko)
|
2018-03-26 |
2021-02-17 |
씨4 테라퓨틱스, 인코포레이티드 |
이카로스의 분해를 위한 세레블론 결합제
|
|
IL298250B2
(en)
|
2018-04-12 |
2025-01-01 |
Bayer Ag |
N-(cyclopropylmethyl)-5-(methylsulfonyl)-N-{1-[1-(pyrimidin-2-yl)-H1-1, 2, 4-triazol-5-yl]ethyl}benzamide derivatives and pyridine-carboxamide derivatives are compatible as pesticides
|
|
WO2019204354A1
(en)
|
2018-04-16 |
2019-10-24 |
C4 Therapeutics, Inc. |
Spirocyclic compounds
|
|
LT3784663T
(lt)
|
2018-04-23 |
2023-10-25 |
Celgene Corporation |
Pakeistieji 4-aminoizoindolin-1,3-diono junginiai ir jų naudojimas limfomos gydymui
|
|
AU2019260016B2
(en)
|
2018-04-25 |
2022-11-17 |
Bayer Aktiengesellschaft |
Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
|
|
EP3578561A1
(en)
|
2018-06-04 |
2019-12-11 |
F. Hoffmann-La Roche AG |
Spiro compounds
|
|
WO2019242625A1
(zh)
*
|
2018-06-20 |
2019-12-26 |
上海科技大学 |
制备来那度胺衍生物的方法
|
|
AU2019390863B2
(en)
*
|
2018-11-28 |
2025-02-20 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
CN113453679B
(zh)
|
2018-12-20 |
2025-07-08 |
C4医药公司 |
靶向蛋白降解
|
|
EP4671268A2
(en)
|
2019-03-21 |
2025-12-31 |
Lonza Sales AG |
METHOD FOR PREPARING EXTRACELLULAR VESICLES
|
|
AU2020241903A1
(en)
|
2019-03-21 |
2021-10-14 |
Lonza Sales Ag |
Extracellular vesicle conjugates and uses thereof
|
|
EP3986397A4
(en)
*
|
2019-06-24 |
2023-05-10 |
Dana-Farber Cancer Institute, Inc. |
Hck degraders and uses thereof
|
|
BR112022000942A2
(pt)
|
2019-07-23 |
2022-05-17 |
Bayer Ag |
Compostos de heteroaril-triazol como pesticidas
|
|
UY38911A
(es)
|
2019-10-09 |
2021-05-31 |
Bayer Ag |
Compuestos de heteroarilo-triazol como pesticidas, formulaciones, usos y métodos de uso de los mismos
|
|
JP2023508914A
(ja)
*
|
2019-12-20 |
2023-03-06 |
カリコ ライフ サイエンシーズ エルエルシー |
プロテインチロシンホスファターゼ分解剤及びその使用方法
|
|
CA3161339A1
(en)
*
|
2019-12-27 |
2021-07-01 |
Schrodinger, Inc. |
Cyclic compounds and methods of using same
|
|
AU2021259858B2
(en)
*
|
2020-04-23 |
2024-12-19 |
University Of Iowa Research Foundation |
GPER proteolytic targeting chimeras
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
US20230192685A1
(en)
|
2020-05-27 |
2023-06-22 |
Takeda Pharmaceutical Company Limited |
Method for producing heterocyclic compound
|
|
WO2021257650A1
(en)
*
|
2020-06-17 |
2021-12-23 |
Dana-Farber Cancer Institute, Inc. |
Targeted aberrant alpha-synuclein species and induced ubiquitination and proteosomal clearance via co-recruitment of an e3-ligase system
|
|
WO2021262969A1
(en)
|
2020-06-24 |
2021-12-30 |
The General Hospital Corporation |
Materials and methods of treating cancer
|
|
WO2022066928A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
CN116710089A
(zh)
*
|
2020-11-12 |
2023-09-05 |
莫诺泰罗斯疗法公司 |
治疗癌症的材料和方法
|
|
JP2024504932A
(ja)
|
2021-01-13 |
2024-02-02 |
モンテ ローザ セラピューティクス， インコーポレイテッド |
イソインドリノン化合物
|
|
WO2022164830A1
(en)
*
|
2021-01-29 |
2022-08-04 |
Eurofins Discoverx Corporation |
Molecular glue screening assays and methods for practicing same
|
|
KR20240130085A
(ko)
|
2021-12-30 |
2024-08-28 |
상하이 한서 바이오메디컬 컴퍼니 리미티드 |
트리시클릭 유도체 억제제, 이의 제조 방법 및 응용
|
|
JP2025503727A
(ja)
*
|
2022-01-18 |
2025-02-04 |
オーリジーン オンコロジー リミテッド |
Ｍａｌｔ－１阻害剤としての置換二環式複素環関連出願の相互参照 この出願は、２０２２年１月１８日に提出されたインド仮特許出願第２０２２４１００２８５９号に対する優先権を主張する。この仮出願の全内容は、参照により本明細書に組み込まれる。
|
|
WO2023143249A1
(zh)
*
|
2022-01-28 |
2023-08-03 |
上海齐鲁制药研究中心有限公司 |
靶向malt1的蛋白降解化合物
|
|
KR20240144146A
(ko)
|
2022-02-02 |
2024-10-02 |
오노 야꾸힝 고교 가부시키가이샤 |
Malt1 저해약을 유효 성분으로서 포함하는 암 치료제
|
|
CN119486728A
(zh)
*
|
2022-02-25 |
2025-02-18 |
特吉德治疗公司 |
粘膜相关淋巴组织淋巴瘤易位蛋白1的蛋白水解靶向嵌合
|
|
EP4536656A1
(en)
|
2022-06-06 |
2025-04-16 |
C4 Therapeutics, Inc. |
Bicyclic-substituted glutarimide cereblon binders
|